These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23254570)

  • 1. Pediatric multiple sclerosis with primary progressive course--report of a retrospective cohort study in Iran.
    Etemadifar M; Afzali P; Tabrizi N; Hosseini SA
    Neuropediatrics; 2013 Jun; 44(3):167-70. PubMed ID: 23254570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
    Maghzi AH; Etemadifar M; Saadatnia M
    Eur J Neurol; 2007 Apr; 14(4):403-7. PubMed ID: 17388988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epileptic seizures in early-onset multiple sclerosis.
    Etemadifar M; Abtahi SH; Tabrizi N
    Arch Iran Med; 2012 Jun; 15(6):381-3. PubMed ID: 22642251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.
    Etemadifar M; Nasr-Esfahani AH; Khodabandehlou R; Maghzi AH
    Arch Iran Med; 2007 Apr; 10(2):152-6. PubMed ID: 17367215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
    Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset multiple sclerosis in Isfahan, Iran.
    Etemadifar M; Abtahi SH; Minagar A; Akbari M; Masaeli A; Tabrizi N
    Arch Iran Med; 2012 Oct; 15(10):596-8. PubMed ID: 23020533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
    De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
    Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics, course and prognosis of spinal multiple sclerosis.
    Nociti V; Cianfoni A; Mirabella M; Caggiula M; Frisullo G; Patanella AK; Sancricca C; Angelucci F; Tonali PA; Batocchi AP
    Spinal Cord; 2005 Dec; 43(12):731-4. PubMed ID: 16010274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
    Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late onset multiple sclerosis].
    Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
    Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
    Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
    Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.
    Atzori M; Battistella PA; Perini P; Calabrese M; Fontanin M; Laverda AM; Suppiej A; Drigo P; Grossi P; Rinaldi L; Gallo P
    Mult Scler; 2009 Mar; 15(3):363-70. PubMed ID: 18987105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria.
    Dujmović I; Mesaros S; Pekmezović T; Lević Z; Drulović J
    Eur J Neurol; 2004 Jul; 11(7):439-44. PubMed ID: 15257680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does cerebrospinal fluid analysis add predictive value to magnetic resonance imaging for long term irreversible disability in patients with early multiple sclerosis?
    Moroso A; Deloire MS; Ruet A; Ouallet JC; Casey R; Brochet B
    J Neurol Sci; 2015 Jul; 354(1-2):51-5. PubMed ID: 25977107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
    Siritho S; Freedman MS
    J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
    Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.